Vol 95, No 4 (2024)
Review paper
Published online: 2024-01-25

open access

Page views 576
Article views/downloads 827
Get Citation

Connect on Social Media

Connect on Social Media

Inflammation in recurrent miscarriage — a comprehensive perspective from uterine microenvironment and immune cell imbalance to therapeutic strategies

Mengsi Lin1, Hui Xu1, Jiaying Qiu1
Pubmed: 38334340
Ginekol Pol 2024;95(4):266-275.


Recurrent miscarriage, poses a significant challenge for many couples globally, the causes of which are not fully understood. Recent studies have shown the intricate link between uterine inflammation and recurrent miscarriages. While inflammation is essential during early pregnancy stages, especially in embryo implantation, an imbalance can lead to miscarriage. Key inflammatory mediators and an imbalance in immune cells can significantly alter and contribute to recurrent miscarriages. Lifestyle factors like smoking and obesity exacerbate inflammatory responses, increasing miscarriage risks. Understanding the interaction between the uterine environment, immune cell imbalances, and recurrent miscarriages is essential for devising effective treatments. This paper presents the latest data on inflammation's role in recurrent miscarriage, emphasizing the significance of diagnosing chronic endometritis and immune imbalances, offering practical recommendations for treatment and diagnosis.

Article available in PDF format

View PDF Download PDF file


  1. Rai R, Regan L. Recurrent miscarriage. The Lancet. 2006; 368(9535): 601–611.
  2. Eskandarian M, Moazzeni SM. Uterine Dendritic Cells Modulation by Mesenchymal Stem Cells Provides A Protective Microenvironment at The Feto-Maternal Interface: Improved Pregnancy Outcome in Abortion-Prone Mice. Cell J. 2019; 21(3): 274–280.
  3. Wang W, Feng D, Ling B. Biologia Futura: endometrial microbiome affects endometrial receptivity from the perspective of the endometrial immune microenvironment. Biol Futur. 2022; 73(3): 291–300.
  4. Krieg S, Westphal L. Immune Function and Recurrent Pregnancy Loss. Semin Reprod Med. 2015; 33(4): 305–312.
  5. Vomstein K, Feil K, Strobel L, et al. Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art. J Clin Med. 2021; 10(4).
  6. Sharma R, Biedenharn KR, Fedor JM, et al. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013; 11: 66.
  7. Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update. 2003; 9(2): 163–174.
  8. Kwak-Kim J, Bao S, Lee SKi, et al. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014; 72(2): 129–140.
  9. Elder S, Bortoletto P, Romanski PA, et al. Chronic endometritis in women with suspected retained products of conception and their reproductive outcomes. Am J Reprod Immunol. 2021; 86(2): e13410.
  10. Kasius JC, Fatemi HM, Bourgain C, et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril. 2011; 96(6): 1451–1456.
  11. McQueen DB, Bernardi LA, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril. 2014; 101(4): 1026–1030.
  12. McQueen DB, Perfetto CO, Hazard FK, et al. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril. 2015; 104(4): 927–931.
  13. Kimura F, Takebayashi A, Ishida M, et al. Review: Chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019; 45(5): 951–960.
  14. Bouet PE, El Hachem H, Monceau E, et al. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril. 2016; 105(1): 106–110.
  15. Biberoglu E, Kirbas A, Daglar K, et al. Role of inflammation in intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res. 2016; 42(3): 252–257.
  16. Moreno I, Cicinelli E, Garcia-Grau I, et al. The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. Am J Obstet Gynecol. 2018; 218(6): 602.e1–602.e16.
  17. Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med. 2014; 32(1): 35–42.
  18. Hashimoto T, Kyono K. Does dysbiotic endometrium affect blastocyst implantation in IVF patients? J Assist Reprod Genet. 2019; 36(12): 2471–2479.
  19. Cicinelli E, Matteo M, Tinelli R, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod. 2015; 30(2): 323–330.
  20. Bardos J, Fiorentino D, Longman RE, et al. Immunological Role of the Maternal Uterine Microbiome in Pregnancy: Pregnancies Pathologies and Alterated Microbiota. Front Immunol. 2019; 10: 2823.
  21. Liu J, Wu S, Wang ZK, et al. Effect of different antibiotic therapies on the reproductive outcomes of fresh embryo transfer for chronic endometritis: A retrospective cohort study. Am J Reprod Immunol. 2023; 89(3): e13669.
  22. Liu J, Liu ZAi, Liu Y, et al. Impact of antibiotic treatment for chronic endometritis on pregnancy outcomes in women with reproductive failures (RIF and RPL): A systematic review and meta-analysis. Front Med (Lausanne). 2022; 9: 980511.
  23. Zhang X, Wei H. Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. Front Immunol. 2021; 12: 728291.
  24. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014; 124(5): 1872–1879.
  25. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001; 60(3): 349–356.
  26. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995; 63(3): 289–302.
  27. Johnson RW. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci. 1997; 75(5): 1244–1255.
  28. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update. 2006; 12(3): 209–232.
  29. Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clin Rev Allergy Immunol. 2017; 53(1): 40–53.
  30. Abramiuk M, Grywalska E, Małkowska P, et al. The Role of the Immune System in the Development of Endometriosis. Cells. 2022; 11(13): 2028.
  31. Lédée N, Petitbarat M, Prat-Ellenberg L, et al. The uterine immune profile: A method for individualizing the management of women who have failed to implant an embryo after IVF/ICSI. J Reprod Immunol. 2020; 142: 103207.
  32. Liu Y, Chen H, Feng L, et al. Interactions between gut microbiota and metabolites modulate cytokine network imbalances in women with unexplained miscarriage. NPJ Biofilms Microbiomes. 2021; 7(1): 24.
  33. Zhong Z, Wang Y, Wang G, et al. Case Report: TNF-Alpha Inhibitors to Rescue Pregnancy in Women With Potential Pregnancy Loss: A Report of Ten Cases. Front Immunol. 2022; 13: 900537.
  34. Banerjee P, Ghosh S, Dutta M, et al. Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage. PLoS One. 2013; 8(11): e80940.
  35. Jasper MJ, Tremellen KP, Robertson SA. Reduced expression of IL-6 and IL-1alpha mRNAs in secretory phase endometrium of women with recurrent miscarriage. J Reprod Immunol. 2007; 73(1): 74–84.
  36. Mariee N, Li TC, Laird SM. Expression of leukaemia inhibitory factor and interleukin 15 in endometrium of women with recurrent implantation failure after IVF; correlation with the number of endometrial natural killer cells. Hum Reprod. 2012; 27(7): 1946–1954.
  37. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2001; 75(4): 683–687.
  38. Pantos K, Grigoriadis S, Maziotis E, et al. The Role of Interleukins in Recurrent Implantation Failure: A Comprehensive Review of the Literature. Int J Mol Sci. 2022; 23(4).
  39. Tao Yu, Li YH, Piao HL, et al. CD56(bright)CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy. Cell Mol Immunol. 2015; 12(1): 77–86.
  40. Xu X, Zhou Y, Wei H. Roles of HLA-G in the Maternal-Fetal Immune Microenvironment. Front Immunol. 2020; 11: 592010.
  41. Wei H, Liu Su, Lian R, et al. Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage. Reprod Sci. 2020; 27(8): 1656–1664.
  42. Yang X, Tian Y, Zheng L, et al. The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses. Int J Mol Sci. 2022; 24(1).
  43. Palomares O, Martín-Fontecha M, Lauener R, et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun. 2014; 15(8): 511–520.
  44. Sanjabi S, Zenewicz LA, Kamanaka M, et al. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009; 9(4): 447–453.
  45. Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 2006; 117(4): 433–442.
  46. Nagaeva O, Jonsson L, Mincheva-Nilsson L. Dominant IL-10 and TGF-beta mRNA expression in gammadeltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol. 2002; 48(1): 9–17.
  47. Terzieva A, Dimitrova V, Djerov L, et al. Early Pregnancy Human Decidua is Enriched with Activated, Fully Differentiated and Pro-Inflammatory Gamma/Delta T Cells with Diverse TCR Repertoires. Int J Mol Sci. 2019; 20(3).
  48. Wang WJ, Hao CF, Qu QL, et al. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 2010; 25(10): 2591–2596.
  49. Alkhuriji A, Omar SAl, Babay Z, et al. Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome. Dis Markers. 2020; 2020: 1–8.
  50. Ma J, Zhang X, He G, et al. Association between TNF, IL1B, IL6, IL10 and IFNG polymorphisms and recurrent miscarriage: a case control study. Reprod Biol Endocrinol. 2017; 15(1): 83.
  51. Vesce F, Battisti C, Crudo M. The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia. Front Immunol. 2022; 13: 861245.
  52. Bagkou Dimakou D, Lissauer D, Tamblyn J, et al. Understanding human immunity in idiopathic recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2022; 270: 17–29.
  53. Niringiyumukiza JD, Cai H, Xiang W. Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation. Reprod Biol Endocrinol. 2018; 16(1): 43.
  54. Mayoral Andrade G, Vásquez Martínez G, Pérez-Campos Mayoral L, et al. Molecules and Prostaglandins Related to Embryo Tolerance. Front Immunol. 2020; 11: 555414.
  55. Nannan Mi, Xiaoping L, Ying J. Periodontal disease in pregnancy and adverse pregnancy outcomes: Progress in related mechanisms and management strategies. Front Med (Lausanne). 2022; 9: 963956.
  56. Zhang S, Lin H, Kong S, et al. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013; 34(5): 939–980.
  57. Reyes L, Phillips P, Wolfe B, et al. and adverse pregnancy outcome. J Oral Microbiol. 2018; 10(1): 1374153.
  58. Wang W, Sung N, Gilman-Sachs A, et al. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front Immunol. 2020; 11: 2025.
  59. Lee JiY, Lee M, Lee SKi. Role of endometrial immune cells in implantation. Clin Exp Reprod Med. 2011; 38(3): 119–125.
  60. Huang N, Chi H, Qiao J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Front Immunol. 2020; 11: 1023.
  61. Tsuda S, Nakashima A, Shima T, et al. New Paradigm in the Role of Regulatory T Cells During Pregnancy. Front Immunol. 2019; 10: 573.
  62. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009; 15(5): 517–535.
  63. Keller CC, Eikmans M, van der Hoorn MLP, et al. Recurrent miscarriages and the association with regulatory T cells; A systematic review. J Reprod Immunol. 2020; 139: 103105.
  64. Crosby DA, Glover LE, Brennan EP, et al. Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment. Hum Reprod. 2020; 35(8): 1875–1888.
  65. Pallmer K, Oxenius A. Recognition and Regulation of T Cells by NK Cells. Front Immunol. 2016; 7: 251.
  66. Jena MK, Nayak N, Chen K, et al. Role of Macrophages in Pregnancy and Related Complications. Arch Immunol Ther Exp (Warsz). 2019; 67(5): 295–309.
  67. Savva C, Copson E, Johnson PWM, et al. Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies. Cancers (Basel). 2023; 15(9).
  68. Li D, Zheng L, Zhao D, et al. The Role of Immune Cells in Recurrent Spontaneous Abortion. Reprod Sci. 2021; 28(12): 3303–3315.
  69. Ding J, Yin T, Yan N, et al. FasL on decidual macrophages mediates trophoblast apoptosis: A potential cause of recurrent miscarriage. Int J Mol Med. 2019; 43(6): 2376–2386.
  70. Xie M, Li Y, Meng YZ, et al. Uterine Natural Killer Cells: A Rising Star in Human Pregnancy Regulation. Front Immunol. 2022; 13: 918550.
  71. Sharma S. Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol. 2014; 58(2-4): 219–229.
  72. Sfakianoudis K, Rapani A, Grigoriadis S, et al. The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment. Biomedicines. 2021; 9(10): 1425.
  73. Woon EeV, Nikolaou D, MacLaran K, et al. Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure. Front Immunol. 2022; 13: 1108163.
  74. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014; 20(3): 429–438.
  75. Quenby S, Kalumbi C, Bates M, et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril. 2005; 84(4): 980–984.
  76. Tang AW, Alfirevic Z, Turner MA, et al. Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials. 2009; 10: 102.
  77. El Hachem H, Crepaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives. Int J Womens Health. 2017; 9: 331–345.
  78. Faas MM, de Vos P. Uterine NK cells and macrophages in pregnancy. Placenta. 2017; 56: 44–52.
  79. Devvanshi H, Kachhwaha R, Manhswita A, et al. Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes. Front Pharmacol. 2022; 13: 895254.
  80. Ishida Y, Zhao D, Ohkuchi A, et al. Maternal peripheral blood natural killer cells incorporate placenta-associated microRNAs during pregnancy. Int J Mol Med. 2015; 35(6): 1511–1524.
  81. Kalkunte SS, Mselle TF, Norris WE, et al. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol. 2009; 182(7): 4085–4092.
  82. Ghafourian M, Karami N, Khodadadi A, et al. Increase of CD69, CD161 and CD94 on NK cells in women with recurrent spontaneous abortion and in vitro fertilization failure. Iran J Immunol. 2014; 11(2): 84–96.
  83. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002; 2(9): 656–663.
  84. Lash GE, Schiessl B, Kirkley M, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006; 80(3): 572–580.
  85. Saghian R, Bogle G, James JL, et al. Establishment of maternal blood supply to the placenta: insights into plugging, unplugging and trophoblast behaviour from an agent-based model. Interface Focus. 2019; 9(5): 20190019.
  86. Robson A, Harris LK, Innes BA, et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 2012; 26(12): 4876–4885.
  87. Pollheimer J, Vondra S, Baltayeva J, et al. Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment. Front Immunol. 2018; 9: 2597.
  88. Mahajan D, Sharma N, Kancharla S, et al. Role of Natural Killer Cells during Pregnancy and Related Complications. Biomolecules. 2022; 12(1): 68.
  89. Walton EL. The inflammasome: Friend or foe in Chlamydia infection? Biomed J. 2016; 39(5): 299–303.
  90. Grewal K, Lee YS, Smith A, et al. Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation. BMC Med. 2022; 20(1): 38.
  91. Buzzaccarini G, Vitagliano A, Andrisani A, et al. Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review. J Assist Reprod Genet. 2020; 37(12): 2897–2911.
  92. Cicinelli E, Matteo M, Tinelli R, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014; 21(5): 640–647.
  93. Khedkar R, Pajai S. Bacterial Vaginosis: A Comprehensive Narrative on the Etiology, Clinical Features, and Management Approach. Cureus. 2022; 14(11): e31314.
  94. Turesheva A, Aimagambetova G, Ukybassova T, et al. Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box. J Clin Med. 2023; 12(12).
  95. Malhotra M, Sood S, Mukherjee A, et al. Genital Chlamydia trachomatis: an update. Indian J Med Res. 2013; 138(3): 303–316.
  96. Pacchiarotti A, Sbracia M, Mohamed MA, et al. Autoimmune response to Chlamydia trachomatis infection and in vitro fertilization outcome. Fertil Steril. 2009; 91(3): 946–948.
  97. Baud D, Goy G, Jaton K, et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis. 2011; 17(9): 1630–1635.
  98. Racicot K, Mor G. Risks associated with viral infections during pregnancy. Journal of Clinical Investigation. 2017; 127(5): 1591–1599.
  99. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004; 329(7477): 1283–1285.
  100. Giakoumelou S, Wheelhouse N, Cuschieri K, et al. The role of infection in miscarriage. Hum Reprod Update. 2016; 22(1): 116–133.
  101. Phupong V. Dengue fever in pregnancy: a case report. BMC Pregnancy Childbirth. 2001; 1(1): 7.
  102. Cornish EF, Filipovic I, Åsenius F, et al. Innate Immune Responses to Acute Viral Infection During Pregnancy. Front Immunol. 2020; 11: 572567.
  103. Chudnovets A, Liu J, Narasimhan H, et al. Role of Inflammation in Virus Pathogenesis during Pregnancy. J Virol. 2020; 95(2).
  104. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011; 342: d2616.
  105. Heydarifard Z, Zadheidar S, Yavarian J, et al. Potential role of viral infections in miscarriage and insights into the underlying molecular mechanisms. Congenit Anom (Kyoto). 2022; 62(2): 54–67.
  106. Di Prima FAF, Valenti O, Hyseni E, et al. Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med. 2011; 5: 41–53.
  107. Gao R, Zeng X, Qin L. Systemic autoimmune diseases and recurrent pregnancy loss: research progress in diagnosis and treatment. Chin Med J (Engl). 2021; 134(17): 2140–2142.
  108. Marder W. Update on pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol. 2019; 31(6): 650–658.
  109. Gluhovschi C, Gluhovschi G, Petrica L, et al. Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma. J Immunol Res. 2015; 2015: 241547.
  110. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005; 32(9): 1709–1712.
  111. Ruiz D, Oates JC, Kamen DL. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. Am J Med Sci. 2018; 355(3): 293–298.
  112. Santos Td, Ieque AL, de Carvalho HC, et al. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. J Reprod Immunol. 2017; 123: 78–87.
  113. Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol. 2001; 96(1): 37–50.
  114. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996; 174(5): 1584–1589.
  115. Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005; 2005(2): CD002859.
  116. Abdullahi ZG, Abdul MA, Aminu SM, et al. Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria. Ann Afr Med. 2016; 15(3): 133–137.
  117. Alijotas-Reig J, Garrido-Gimenez C. Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv. 2013; 68(6): 445–466.
  118. Ghimire PR, Akombi-Inyang BJ, Tannous C, et al. Association between obesity and miscarriage among women of reproductive age in Nepal. PLoS One. 2020; 15(8): e0236435.
  119. Moore TA, Ahmad IM, Schmid KK, et al. Oxidative Stress Levels Throughout Pregnancy, at Birth, and in the Neonate. Biol Res Nurs. 2019; 21(5): 485–494.
  120. Ardalić D, Stefanović A, Kotur-Stevuljević J, et al. The influence of maternal smoking habits before pregnancy and antioxidative supplementation during pregnancy on oxidative stress status in a non-complicated pregnancy. Adv Clin Exp Med. 2014; 23(4): 575–583.
  121. Firns S, Cruzat VF, Keane KN, et al. The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data. Reprod Biol Endocrinol. 2015; 13: 134.
  122. Grippo A, Zhang J, Chu Li, et al. Air pollution exposure during pregnancy and spontaneous abortion and stillbirth. Rev Environ Health. 2018; 33(3): 247–264.
  123. Martins Costa Gomes G, Karmaus W, Murphy VE, et al. Environmental Air Pollutants Inhaled during Pregnancy Are Associated with Altered Cord Blood Immune Cell Profiles. Int J Environ Res Public Health. 2021; 18(14).
  124. Magnus MC, Hockey RL, Håberg SE, et al. Pre-pregnancy lifestyle characteristics and risk of miscarriage: the Australian Longitudinal Study on Women's Health. BMC Pregnancy Childbirth. 2022; 22(1): 169.
  125. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147.
  126. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003; 327(7411): 368.
  127. Shi Y, Tan D, Hao B, et al. Efficacy of intravenous immunoglobulin in the treatment of recurrent spontaneous abortion: A systematic review and meta-analysis. Am J Reprod Immunol. 2022; 88(5): e13615.
  128. Habets DHJ, Pelzner K, Wieten L, et al. Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2022; 18(1): 23.
  129. Hamulyák EN, Scheres LJj, Marijnen MC, et al. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020; 5(5): CD012852.
  130. Baiazid L, Hraib M. Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome. Ann Med Surg (Lond). 2022; 83: 104807.
  131. Talukdar A, Rai R, Aparna Sharma K, et al. Peripheral Gamma Delta T cells secrete inflammatory cytokines in women with idiopathic recurrent pregnancy loss. Cytokine. 2018; 102: 117–122.
  132. Agarwal A, Rana M, Qiu E, et al. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018; 50(11): e13126.